Fibronectin and C-reactive protein in pregnancy induced hypertension

Jugoslovenska Medicinska Biohemija

Volumn 22, Issue 4, 2003, Pages 325-328

  Duričić, Svetlana ^a   Stojanov, Marina ^b   Obradović, Ivana ^c   Glišić, Aleksandar ^c   Plećaš, Darko ^c  

^a Health Centre   (Poland)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

C reactive protein; Fibronectin; Pregnancy induced hypertension

Indexed keywords

C REACTIVE PROTEIN; FIBRONECTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM INJURY; FEMALE; HUMAN; MATERNAL HYPERTENSION; NEPHELOMETRY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; SCREENING;

EID: 0345169720     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0304325D     Document Type: Article

References (14)

1. Redman CWG. The definition of pre-eclampsia. Scand J Clin Lab Invest 1984; 169: 7.
2. O'Brien FW. The prediction of pre-eclampsia. Clin Obsret Gynecol 1992; 35: 351-364.
3. Taylor RN, Casal DC, Lynn AJ, Varma M, Martin JN, Roberts JM. Selective effects of pre-eclamptic sera on human endothelial cell procoagulant protein expression. Am J Obstret Gynecol 1991; 165: 1705-10.
4. Saleh AA, Bottoms SF, Norman G, Faray AM, Mamman EF. Hemostatis in hypertensive disorders of pregnancy. Obstret Gynecol 1988; 71: 719-22.
5. Shaaraway M, Didy HE. Thrombomodulin, plasminogen activator type 1 (PAI-1) And fibronectin as biomarkers of endothelial damage in pre-eclampsia and eclampsia. Int J Gynecol Obstret 1996; 55(2): 135-9.
6. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Pre-eclampsia: an endothelial cell disorder. J Obstet Gynecol 1989; 161: 1200-4.
7. Ballegeer VC, Spitz B, De Baene LA, Van Assche AF, Hidajat M, Criel AM. Platelet activation and vascular damage in gastrointestinal hypertension. Am J Obstret Gynecol 1992; 166 (2): 629-33.
8. Pipkin FB. Fortnightly Review: The hypertension disorders of pregnancy. Br Med Journal 1995; 311: 609-13.
9. Leduc L, Wheeler JM, Kirshon B, Mitchell P, Cotton DB. Coagulation profile in severe pre-eclampsia. Obstret Gynecol 1992; 79: 14-8.
10. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing vascular disease. Circulation 1998; 97 (5): 425-8.
11. Oslund E, Hansson LO, Bremme K. Fibronectin is a marker for organ involvement and may reflect the severity of pre-eclampsia. Hypertens Pregnancy 2001; 20 (1): 79-87.
12. Satter N. The link between obesty, low-grade inflammation, and pre-eclampsia. Obstretics and Gynecology 2001; 1: 75-81.
13. Gredmark T, Bergman B, Hellstrom L. Total fibronectin in maternal plasma as predictor for pre-eclampsia. Gynecol Obstret Invest 1999; 47 (2): 89-94.
14. Hayaski M, Inone T, Hashimoto K, Negishi H, Ohkura T, Inaba N. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. Eur J Haematol 2002; 69 (5-6): 297-302.